Abstract/Description
BACKGROUND:
Pulmonary embolism (PE) is a dangerous and life-threatening medical condition which significantly increases risk of cardiovascular fatality. Although each PE treatment strategy has shown to be effective to some degree, there is limited data on they compare. The objective of this study is to evaluate the outcomes of PE treatment with anticoagulation versus interventional treatments.
METHODS:
A Retrospective chart review was performed of all patients identified as having a PE at Sentara Norfolk General Hospital from January 1, 2021 to December 31, 2022. Using Redcap, patient information was recorded, including age, sex, race, body mass index, and pertinent history. Information about their condition and details of the pulmonary embolism were recorded, including vitals, labs, and heart function obtained from echocardiograms. The intervention type was recorded, with details of any procedures as well as the in hospital or 30-day mortality.
RESULTS:
These are the preliminary results for comparing outcomes of pulmonary embolism treatment options. 366 patients were analyzed, with 197 female and 169 males having an average age of 65.5 years. The most common treatment was anticoagulation therapy only (60.2%), followed by mechanical thrombectomy (12.8%), systemic tPA (11.4%), CDT with EKOS (11.2%), and CDT with tPA (4.1%). 45 patients suffered an in-hospital death or mortality within 30 days of treatment (12.3%)
CONCLUSIONS:
The majority of patients who had an unsuccessful outcome were treated with anticoagulation therapy only. However, the treatment with the lowest success rate was systemic tPA.
Faculty Advisor/Mentor
Animesh Rathore MD
Faculty Advisor/Mentor Department
Department of Vascular Surgery
College/School/Affiliation
Eastern Virginia Medical School (EVMS)
Included in
Comparing Immediate and Short-term Outcomes and Success in Conservative Versus Surgical Treatment of Pulmonary Embolism (PE)
BACKGROUND:
Pulmonary embolism (PE) is a dangerous and life-threatening medical condition which significantly increases risk of cardiovascular fatality. Although each PE treatment strategy has shown to be effective to some degree, there is limited data on they compare. The objective of this study is to evaluate the outcomes of PE treatment with anticoagulation versus interventional treatments.
METHODS:
A Retrospective chart review was performed of all patients identified as having a PE at Sentara Norfolk General Hospital from January 1, 2021 to December 31, 2022. Using Redcap, patient information was recorded, including age, sex, race, body mass index, and pertinent history. Information about their condition and details of the pulmonary embolism were recorded, including vitals, labs, and heart function obtained from echocardiograms. The intervention type was recorded, with details of any procedures as well as the in hospital or 30-day mortality.
RESULTS:
These are the preliminary results for comparing outcomes of pulmonary embolism treatment options. 366 patients were analyzed, with 197 female and 169 males having an average age of 65.5 years. The most common treatment was anticoagulation therapy only (60.2%), followed by mechanical thrombectomy (12.8%), systemic tPA (11.4%), CDT with EKOS (11.2%), and CDT with tPA (4.1%). 45 patients suffered an in-hospital death or mortality within 30 days of treatment (12.3%)
CONCLUSIONS:
The majority of patients who had an unsuccessful outcome were treated with anticoagulation therapy only. However, the treatment with the lowest success rate was systemic tPA.